Literature DB >> 19435753

Multiple sclerosis in China--history and future.

Q Cheng1, X-J Cheng, G-X Jiang.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is considered rare in China and reports on MS in the English literature are few.
METHODS: A systematic literature search for articles with MS was made, particularly for papers published in the Chinese medical journals from mainland China.
RESULTS: In China, the first case of MS was described in the medical records from Xiehe hospital in 1926, and the first autopsy case of MS was reported from Huashan hospital in 1957. Although reports on MS based on the information from hospital case-series have been increased gradually in the recent decades, there is no national surveillance on MS frequency in the population and population-based surveys on MS were few in China. Generally for Chinese patients with MS the mean age at onset of MS is around 30 years, with a few cases younger than 20 years; the most frequent site of the lesions in the central nervous system, based on the clinical symptoms or signs, is the spinal cord (usually more than 60%); there are few patients with a family history of MS; almost all patients are treated with corticosteroids. Reported prevalence rates of MS from population surveys in China are rather low (1-2 per 100,000) and higher in females than in males, which are comparable with the results from other populations in Asia.
CONCLUSION: The clinical and epidemiological aspects of MS in China are, in general, similar to that from other populations in Asia. Epidemiological studies and national surveillance on MS are required in China.

Entities:  

Mesh:

Year:  2009        PMID: 19435753     DOI: 10.1177/1352458509102921

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Hypothalamus syndrome in opticospinal multiple sclerosis.

Authors:  Y Zhang; R Dong; H Fan; S Li; D Geng
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

Review 2.  The "Treatise on the spleen and stomach" (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine.

Authors:  Andréa D Fuzimoto; Francesco Brigo
Journal:  J Tradit Complement Med       Date:  2020-03-02

3.  Intrinsic functional plasticity of the sensorimotor network in relapsing-remitting multiple sclerosis: evidence from a centrality analysis.

Authors:  Ying Zhuang; Fuqing Zhou; Honghan Gong
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.

Authors:  Kristy Purnamawati; Jamie Ann-Hui Ong; Siddharth Deshpande; Warren Kok-Yong Tan; Nihar Masurkar; Jackson Kwee Low; Chester Lee Drum
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

5.  Social and professional consequences of COVID-19 lockdown in patients with multiple sclerosis from two very different populations.

Authors:  G X Zhang; C Sanabria; D Martínez; W T Zhang; S S Gao; A Alemán; A Granja; C Páramo; M Borges; G Izquierdo
Journal:  Neurologia (Engl Ed)       Date:  2020-08-13

Review 6.  The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review.

Authors:  Dongmei Jia; Yu Zhang; Chunsheng Yang
Journal:  Neurol Sci       Date:  2022-05-18       Impact factor: 3.830

7.  Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study.

Authors:  De-Cai Tian; Zixiao Li; Meng Yuan; Chengyi Zhang; Hongqiu Gu; Yongjun Wang; Fu-Dong Shi
Journal:  Lancet Reg Health West Pac       Date:  2020-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.